DSM and PBC Partnership to develop regenerative bone adhesives


DSM and PBC Biomed partner to develop regenerative bone adhesives for safer, more cost-effective surgical procedures.

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and PBC Biomed, a medical device design and development company, have signed an agreement to jointly design and develop novel materials for medical devices. Initially, the agreement will focus on the development of bone adhesives through PBC Biomed’s affiliate, Biomimetic Innovations, which could help to meet the need for safer, less invasive surgical procedures that are also more cost-effective.

Through this cooperation, DSM and PBC Biomed aim to strengthen their respective abilities to help medical device companies develop products that address the growing trends in medicine, from treating an aging population to caring for a more active one. The partners will initially focus on developing Biomimetic Innovations’ proof-of-concept for regenerative bone adhesives which promise shorter operation times, lower infection rates, and better healing outcomes for patients.

Marc Hendriks, Senior Director Strategy and Business Development for DSM Biomedical, said: “We look forward to partnering with PBC Biomed and contributing DSM’s biomaterials leadership and expertise towards the further development of bone adhesives and many others. Bone adhesives have the potential to transform orthopedics and vastly improve patient outcomes; in full support of our Vision of solving the world’s healthcare needs through sustainable science.”

Paul Burke, Managing Partner for PBC Biomed, said: “PBC Biomed is celebrating our 10th year of partnering with companies large and small to deliver science-based innovations in the medical device, biologic and pharmaceutical sectors. This agreement with Royal DSM brings us closer to our joint goal of accelerating medical innovation and enhancing patient wellness in the orthopaedic space.”

DSM has more than 30 years’ experience serving the medical device industry with world-class medical technologies and materials, and PBC Biomed has an impressive track record of science-based innovation in partnership with small, medium and global medical companies. Through the partnership, the companies aim to leverage their complementary technologies and capabilities to serve customers in the medical device industry with an integrated solution offering comprising materials design, product development, manufacturing process development, and manufacturing services.

DSM – Bright Science. Brighter Living.™

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.